Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Allman

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
The Annals of Thoracic Surgery|August 26, 2021
Thromboelastography-Platelet Mapping Allows Safe and Earlier Urgent Coronary Artery Bypass GraftingAustin L Rogers, Robert D Allman, Xiangming Fang, et al.
Cold Spring Harbor Symposia on Quantitative Biology|March 10, 2001
Consequences of Notch-mediated inhibition of the transcription factor E47W Pear, Z Tang, S DeRocco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patientsB Reigner, J Verweij, L Dirix, et al.
International Journal of Clinical Practice|June 22, 2010
How ethical is your clinical trial?L Miller, M Folayan, D Allman, et al.
Journal of Cardiac Surgery|October 13, 2021
Response to Letter to the Editor-Analysis of racial disparities in acute type A aortic dissection repair at a rural tertiary academic medical centerBenjamin C Degner, Shahab A Akhter, Robert D Allman, et al.
Journal of Cardiac Surgery|September 9, 2021
Analysis of racial disparities in acute type A aortic dissection repair at a rural tertiary academic medical centerRobert D Allman, Austin L Rogers, Patrycja Popowicz, et al.
Urologic Oncology|August 23, 2018
The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy eraYu-Wei Chen, Moshe C Ornstein, Laura S Wood, et al.
Journal for Immunotherapy of Cancer|May 18, 2019
A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapyMoshe C Ornstein, Laura S Wood, Brian P Hobbs, et al.
The Journal of Experimental Medicine|July 4, 2001
Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cellsD Allman, F G Karnell, J A Punt, et al.
Clinical Genitourinary Cancer|August 18, 2020
Clinical Activity of Ipilimumab Plus Nivolumab in Patients With Metastatic Non-Clear Cell Renal Cell CarcinomaRuby Gupta, Moshe Chaim Ornstein, Hong Li, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
The Annals of Thoracic Surgery|August 26, 2021
Thromboelastography-Platelet Mapping Allows Safe and Earlier Urgent Coronary Artery Bypass GraftingAustin L Rogers, Robert D Allman, Xiangming Fang, et al.
Cold Spring Harbor Symposia on Quantitative Biology|March 10, 2001
Consequences of Notch-mediated inhibition of the transcription factor E47W Pear, Z Tang, S DeRocco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patientsB Reigner, J Verweij, L Dirix, et al.
International Journal of Clinical Practice|June 22, 2010
How ethical is your clinical trial?L Miller, M Folayan, D Allman, et al.
Journal of Cardiac Surgery|October 13, 2021
Response to Letter to the Editor-Analysis of racial disparities in acute type A aortic dissection repair at a rural tertiary academic medical centerBenjamin C Degner, Shahab A Akhter, Robert D Allman, et al.
Journal of Cardiac Surgery|September 9, 2021
Analysis of racial disparities in acute type A aortic dissection repair at a rural tertiary academic medical centerRobert D Allman, Austin L Rogers, Patrycja Popowicz, et al.
Urologic Oncology|August 23, 2018
The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy eraYu-Wei Chen, Moshe C Ornstein, Laura S Wood, et al.
Journal for Immunotherapy of Cancer|May 18, 2019
A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapyMoshe C Ornstein, Laura S Wood, Brian P Hobbs, et al.
The Journal of Experimental Medicine|July 4, 2001
Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cellsD Allman, F G Karnell, J A Punt, et al.
Clinical Genitourinary Cancer|August 18, 2020
Clinical Activity of Ipilimumab Plus Nivolumab in Patients With Metastatic Non-Clear Cell Renal Cell CarcinomaRuby Gupta, Moshe Chaim Ornstein, Hong Li, et al.
Pageof 5